ABEO,Abeona Therapeutics Inc. | Healthcare

Healthcare

ABEO

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Abeona Therapeutics Inc.ABEO

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa.

The company also develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy.

In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015.

Abeona Therapeutics Inc. is headquartered in New York, New York.

Latest News >

Ford says Michigan EV battery plant 'on track' for production tax credits

Jul 8, 2025

(Reuters) -Ford Motor ( F ) said Tuesday it believes its planned $3 billion Michigan electric vehicle battery plant, which is 60% complete, will qualify for production tax credits after a massive tax and budget bill revised the rules. In May, Ford had sounded the alarm over the potential for the U.S. government to eliminate production tax credits that support...

Asian nations push for US tariff concessions before August deadline

Jul 8, 2025

WASHINGTON/TOKYO (Reuters) -Powerhouse Asian economies Japan and South Korea said on Tuesday they would try to negotiate with the U.S. to soften the impact of sharply higher tariffs that President Donald Trump now plans to impose from the start of August. Trump ramped up his trade war again on Monday, telling 14 nations that they would face tariffs ranging from...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

MIDEAST STOCKS-Gulf stocks mixed on US tariff uncertainty

Jul 8, 2025

By Amna Mariyam July 8 (Reuters) - Gulf equities ended mixed on Tuesday, with investors exercising caution over U.S. trade policies after President Donald Trump announced steep import levies on several trading partners and pushed the tariff deadline to August 1. While Gulf economies were spared from immediate measures, Trump had earlier announced plans to impose an additional 10% tariff...